X chromosome, injury and infection

X染色体、损伤和感染

基本信息

项目摘要

DESCRIPTION (provided by applicant): Females as compared to males display better general health status, longer life span and improved clinical course after injury and infection. It is generally believed that the female advantage is associated with the effects of sex hormones. This project will test the question of whether the presence of cellular mosaicism of X chromosome-linked protein variants in females represents a functionally adaptive cellular system that is advantageous during the host response to infections. Cells from females carry both parental X chromosomes (maternal, Xm and paternal, Xp) whereas males carry only one X chromosome that is derived from the mother (Xm). As the result of dosage compensation and random X inactivation, half of the cells from females express proteins either from Xm or Xp, respectively. Therefore, females are cellular mosaics for X-linked polymorphic proteins. Several genes encoding key regulatory and metabolic proteins involved in the innate immune response reside on the X chromosome. The study focuses on two X-linked proteins, the first, gp91phox (Cybb) is a critical protein component of the NADPH oxidase complex that produces superoxide anion required for bacterial killing; the second, IRAK1 (IL-1 receptor associated kinase-1) is an important component of TLR-mediated cell signaling pathway. The investigations will employ experimental models of endotoxemia and sepsis utilizing mouse strains that carry genetically silenced forms of these X-linked proteins. Changes in blood and bone marrow cell compositions as well as phagocyte infiltration into lung, spleen and liver will be tested following sepsis or endotoxemia. Observations will be compared between mosaics and single-population homo/hemizygous deficient or WT animals. Alterations in cell signaling, cytokine production and redox-dependent cell functions will also be determined and compared. We hypothesize that female mosaics will display acute heterogeneous functional adaptation that will be associated with improved outcome following sepsis or endotoxemia. This will be reflected in skewed cell composition and cell activation toward mosaic subpopulations expressing the advantageous alleles together with improved bacterial killing and survival. The studies will broaden our understanding of the cellular and biochemical mechanisms responsible for immuno-modulation by X- chromosome mosaicism and gender and may open new perspectives in treating the critically ill. PUBLIC HEALTH RELEVANCE: Small differences in the genetic makeup of individuals, called single nucleotide polymorphisms (SNPs), have been shown to alter the clinical outcomes after injury and infection. In the case of X-chromosome-linked SNPs, males and females are different because females carry both parental X-chromosomes and show cellular X-chromosome mosaicism whereas males carry only one X-chromosome. The studies will test the novel hypothesis that cellular mosaicism for X-linked genetic mutations can benefit the host during the immune response to infections. Better understanding of the protecting cellular mechanisms that are in effect during septic conditions could lead to advanced protocols in treating the critically ill.
描述(由申请人提供):与男性相比,女性表现出更好的总体健康状况、更长的寿命以及受伤和感染后改善的临床病程。人们普遍认为,女性的优势与性激素的作用有关。该项目将测试女性中 X 染色体连锁蛋白变体细胞嵌合的存在是否代表一种功能适应性细胞系统,该系统在宿主对感染的反应过程中是有利的。雌性细胞携带两条亲代 X 染色体(母系 Xm 和父系 Xp),而雄性细胞仅携带一条源自母亲的 X 染色体 (Xm)。由于剂量补偿和随机 X 失活,雌性细胞中有一半分别表达来自 Xm 或 Xp 的蛋白质。因此,雌性是 X 连锁多态蛋白的细胞嵌合体。编码涉及先天免疫反应的关键调节和代谢蛋白的几个基因位于 X 染色体上。该研究重点关注两个 X 连锁蛋白,第一个是 gp91phox (Cybb),它是 NADPH 氧化酶复合物的关键蛋白成分,可产生杀死细菌所需的超氧阴离子;第二个是 gp91phox (Cybb)。第二,IRAK1(IL-1受体相关激酶1)是TLR介导的细胞信号通路的重要组成部分。这些研究将采用内毒素血症和败血症的实验模型,利用携带这些 X 连锁蛋白基因沉默形式的小鼠品系。脓毒症或内毒素血症后,将测试血液和骨髓细胞成分的变化以及吞噬细胞浸润到肺、脾和肝脏的情况。将比较嵌合体和单一群体同源/半合子缺陷或WT动物之间的观察结果。细胞信号传导、细胞因子产生和氧化还原依赖性细胞功能的改变也将被确定和比较。我们假设雌性嵌合体将表现出急性异质性功能适应,这与脓毒症或内毒素血症后结局的改善有关。这将反映在细胞组成的倾斜和细胞活化向表达有利等位基因的嵌合亚群以及改善的细菌杀灭和存活。这些研究将拓宽我们对 X 染色体嵌合和性别免疫调节的细胞和生化机制的理解,并可能为治疗危重疾病开辟新的视角。公共卫生相关性:个体基因组成的微小差异(称为单核苷酸多态性 (SNP))已被证明会改变受伤和感染后的临床结果。就 X 染色体连锁的 SNP 而言,男性和女性是不同的,因为女性携带双亲 X 染色体并显示细胞 X 染色体嵌合体,而男性仅携带一条 X 染色体。这些研究将检验新的假设,即 X 连锁基因突变的细胞嵌合现象可以在对感染的免疫反应过程中使宿主受益。更好地了解脓毒症期间有效的保护细胞机制可能会导致治疗危重疾病的先进方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZOLTAN SPOLARICS其他文献

ZOLTAN SPOLARICS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZOLTAN SPOLARICS', 18)}}的其他基金

X chromosome, injury and infection
X染色体、损伤和感染
  • 批准号:
    8241156
  • 财政年份:
    2009
  • 资助金额:
    $ 28.59万
  • 项目类别:
X chromosome, injury and infection
X染色体、损伤和感染
  • 批准号:
    7797529
  • 财政年份:
    2009
  • 资助金额:
    $ 28.59万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    6938546
  • 财政年份:
    2004
  • 资助金额:
    $ 28.59万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    7117175
  • 财政年份:
    2004
  • 资助金额:
    $ 28.59万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    6821071
  • 财政年份:
    2004
  • 资助金额:
    $ 28.59万
  • 项目类别:
Erythrocytes, immuno-modulation and G6PD deficiency
红细胞、免疫调节和 G6PD 缺乏
  • 批准号:
    7279911
  • 财政年份:
    2004
  • 资助金额:
    $ 28.59万
  • 项目类别:
TRAUMA, G6PD DEFICIENCY AND SEPSIS
创伤、G6PD 缺乏症和败血症
  • 批准号:
    2655021
  • 财政年份:
    1997
  • 资助金额:
    $ 28.59万
  • 项目类别:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
6-磷酸葡萄糖脱氢酶缺乏症和脓毒症
  • 批准号:
    6628867
  • 财政年份:
    1997
  • 资助金额:
    $ 28.59万
  • 项目类别:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
6-磷酸葡萄糖脱氢酶缺乏症和脓毒症
  • 批准号:
    6698545
  • 财政年份:
    1997
  • 资助金额:
    $ 28.59万
  • 项目类别:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
6-磷酸葡萄糖脱氢酶缺乏症和脓毒症
  • 批准号:
    6498741
  • 财政年份:
    1997
  • 资助金额:
    $ 28.59万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.59万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了